Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries
Overview
Authors
Affiliations
Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.
Alam M, Jarvis C, Hincapie R, McKay C, Schimer J, Sanhueza C ACS Nano. 2020; 15(1):309-321.
PMID: 32790346 PMC: 8249087. DOI: 10.1021/acsnano.0c03023.
Liu A, De Rosa S, Guthrie B, Choi R, Kerubo-Bosire R, Richardson B Immun Inflamm Dis. 2018; 6(3):392-401.
PMID: 29974672 PMC: 6113767. DOI: 10.1002/iid3.231.
Chen L, Liu W, Lei J, Guan F, Li M, Song W PLoS One. 2012; 7(12):e51512.
PMID: 23272112 PMC: 3522692. DOI: 10.1371/journal.pone.0051512.
Koesters S, Matu L, Kiama P, Anzala O, Embree J, Plummer F J Clin Immunol. 2004; 24(6):702-9.
PMID: 15622455 DOI: 10.1007/s10875-004-6238-1.
Borkow G, Bentwich Z Clin Microbiol Rev. 2004; 17(4):1012-30, table of contents.
PMID: 15489359 PMC: 523563. DOI: 10.1128/CMR.17.4.1012-1030.2004.